Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,985
datasets available to search
ShareScore release 0.9.0
Dataset results
1,985 results for “Antigen”
The Assessment of Mesothelin Antigen Specific Immunologic Assays in Ovarian Cancer Patients
ClinicalTrials.gov study NCT00173394. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted Alpha Therapy With 225Actinium-Prostate Specific Membrane Antigen (PSMA)-I&T of Castration-resISTant Prostate Cancer (TATCIST).
ClinicalTrials.gov study NCT05219500. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies
ClinicalTrials.gov study NCT04796688. IPD Sharing: NO. Countries: 1. Publications: 0.
Consolidation Therapy With Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19 in Patients With Chronic Lymphocytic Leukemia Following Upfront Chemotherapy With Pentostatin, Cy
ClinicalTrials.gov study NCT01416974. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05336383. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Turnover of Antigen Specific Lymphocytes and Monocytes After Immunization With the 17D Yellow Fever Vaccine
ClinicalTrials.gov study NCT01290055. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study on the Safety and Efficacy of CD7-Targeted Chimeric Antigen Receptor (CAR) Gene-Modified T Cells for the Treatment of CD7-Positive Hematological Malignancies
ClinicalTrials.gov study NCT07345780. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy
ClinicalTrials.gov study NCT05349266. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine
ClinicalTrials.gov study NCT03581903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of MOC31-PE in Antigen Positive Carcinomas
ClinicalTrials.gov study NCT01061645. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening
ClinicalTrials.gov study NCT04322045. IPD Sharing: NO. Countries: 1. Publications: 0.
CD19 Targeted Chimeric Antigen Receptor T Cells for B Cell Lymphoma
ClinicalTrials.gov study NCT03118180. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety and Immunogenicity of Surface Antigen, Inactivated, Adjuvanted With MF59C.1 Influenza Vaccine, Formulation 2008-2009
ClinicalTrials.gov study NCT00734734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepati
ClinicalTrials.gov study NCT02598063. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
ClinicalTrials.gov study NCT02959151. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour
ClinicalTrials.gov study NCT04107142. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants
ClinicalTrials.gov study NCT03953196. IPD Sharing: YES. Countries: 1. Publications: 0.
Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)
ClinicalTrials.gov study NCT06905262. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT05993611. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies
ClinicalTrials.gov study NCT06652633. IPD Sharing: NO. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.